# Phenytoin

## Aleviatin inj 250mg/5mL

| 藥物代碼           | IALE                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Control of status epilepticus of the tonic-clonic (grand mal) type; prevention & treatment of seizures which occur during or following neurosurgery &/or severe head injury                                                                                                                                                                                                                                                                                                        |
| 副作用             | Nystagmus, ataxia, slurred speech, decreased coordination, mental confusion, paraesthesia, drowsiness, vertigo; severe cardiotoxic reactions & fatalities; GI disturbances, scarlatiniform or measles-like rashes; pain & inflammation at inj site; gingival hypertrophy, coarse facies, acne & hirsutism, fever & hepatitis. Rarely, haematological effects, including megaloblastic anaemia, thrombocytopenia, leucopenia, granulocytopenia, agranulocytosis & aplastic anaemia. |
| 禁忌               | Sinus bradycardia, heart block, Stokes-Adams syndrome.                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 藥物保存方式       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 用法用量           | Adult 2.5-5 mL (125-250 mg) by slow IV inj at a rate not exceeding 1 mL/min; an additional dose of 2-3 mL (100-150 mg) may be administered after 30 mins if necessary.                                                                                                                                                                                                                                                                                                             |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 懷孕用藥危分級     | 儘量避免                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 孕期用藥建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 哺乳期用藥建議     | Compatible 哺乳時可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 注射劑給藥建議途徑 | IVD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 輸注點滴液         | 【N/S】 可選                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| IVD 用法建議       | Slow IV,注射速率 < 50mg/min 25℃以下，超過4小時可能會有白色沉澱，需使用0.22 micron fillter過濾                                                                                                                                                                                                                                                                                                                                                                                      |
| 注意事項           | 1.本品為強鹼性，故無法與其他藥品配合，與酸性藥品混合會產生不相容性。PH值降低會析出結晶。 2.在25℃以下，超過4小時可能會有白色沉澱，需使用0.22 micron fillter過濾給藥 3.[Micromedex]稀釋後濃度不可小於 5 mg/mL. 稀釋過後不可冷藏.                                                                                                                                                                                                                                                     |

## Dilantin 100mg

| 藥物代碼           | ODIL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | 主治癲癇、三叉神經痛及其他神經痛(N000817100)Control of generalized tonic-clonic (grand mal) & complex partial (psychomotor, temporal lobe) seizures. Prevention & treatment of seizures occurring during or following neurosurgery.                                                                                                                                                                                                                                                           |
| 副作用             | GI disturbances; ataxia, slurred speech; diplopia, nystagmus & mental confusion with headache, dizziness, gingival hyperplasia, hirsutism, hyperglycemia, osteomalacia.                                                                                                                                                                                                                                                                                                                       |
| 禁忌               | Sinus bradycardia, sino-atrial block, 2nd and 3rd degree AV block or in patients with Adams-Stokes sybdrome.                                                                                                                                                                                                                                                                                                                                                                                  |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 用法用量           | Seizure, During and following neurosurgery; Treatment and Prophylaxis Oral:  Adult: 100 mg tid, adjusted as needed; (max. 600 mg/day).  Child: Initial, 5 mg/kg/day in 2-3 divided doses;  maintenance, 4-8 mg/kg/day;(max. 300 mg/day). Slow IV (not exceeding 50 mg/min): Anticonvulsant (for status epilepticus): Adult & child, loading dose, 15 mg/kg then 5 mg/kg given after 12hrs. Alternatively, 20 mg/kg as a full loading dose. Antiarrhythmic: 100 mg q5mins as needed; (max.1g). |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 懷孕用藥危分級     | 儘量避免                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 孕期用藥建議       | Compatible - maternal benefit >> embryo-fetal risk                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 哺乳期用藥建議     | Compatible 哺乳時可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 附帶說明           | Phenytoin is excreted in breast milk; however, the amount to which the infant is exposed is considered small. The manufacturers of phenytoin do not recommend breast-feeding during therapy.                                                                                                                                                                                                                                                                                                  |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

